Completed OBSERVATIONAL NCT03966105

Prevalence of Wild Type ATTR

Prevalence of Amyloidosis in Patients With Lumbar Spinal Stenosis

Sponsor: Ente Ospedaliero Cantonale, Bellinzona

Conditions Wild-type Transthyretin Amyloidosis

Updated 9 times since 2019 Last updated: Mar 23, 2023 Started: Nov 1, 2019 Primary completion: Oct 31, 2021 Completion: Oct 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Wild-type Transthyretin Amyloidosis and is currently completed. Ente Ospedaliero Cantonale, Bellinzona leads this study, which shows 9 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Apr 2023 — Jul 2024 [monthly]

Completed

Status: Unknown Status → Completed
Nov 2022 — Apr 2023 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Dec 2021 — Nov 2022 [monthly]

Recruiting

▶ Show 4 earlier versions

Jan 2021 — Dec 2021 [monthly]

Recruiting
Nov 2020 — Jan 2021 [monthly]

Recruiting
Oct 2020 — Nov 2020 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Jun 2019 — Oct 2020 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ente Ospedaliero Cantonale, Bellinzona
Oncology Institute of Southern Switzerland
University of Kiel

Data source: Oncology Institute of Southern Switzerland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bellinzona, Switzerland